Human Biosimilar Antibodies
For Research Use Only
Embedded Files
非常適合在人源化小鼠模型等體內使用！
Leinco Technologies 提供高純度研究用等級生物相似藥抗體，其規格與許多治療性抗體藥物相同。
Research-grade biosimilar antibodies
是透過重組技術使用治療性抗體的可變區序列，產生與核准的生物製劑相同的特異性。
Leinco 的重組生物相似藥抗體是理想的研究工具，因為它們快速、便宜、在無動物源設施中製造，並在無菌 PBS 緩衝液中配製，不含添加劑或防腐劑。
產品特點
純度 > 95% 以上 (SDS-PAGE)。
monomer > 98% 以上 (analytical SEC)。
內毒素 ≤ 0.5 EU/mg (LAL method)。
在 animal-free 設施使用無 protein-free、animal-origin-free 細胞培養基製造。
超低 Protein A 殘留。
採用 Leinco's in vivo 等級標準的 PBS pH 7.2 無菌過濾和配製，不含 K 或 Ca 離子，無添加劑、防腐劑或 carrier protein。
多種應用，包括 FC、ELISA、IHC、FA、PK、效價測定和 IVD。
病原體測試（IMPACT1）。
產品列表
Research-Grade Biosimilars: For FC, IHC, ELISA, and more!
Biotherapeutic Antibody
Specificity
Biotherapeutic Antibody
Specificity
Adalimumab
Anti-Human TNFα
Belantamab
Anti-Human BCMA
Alemtuzumab
Anti-Human CD52
Bevacizumab
Anti-Human VEGF
Anifrolumab
Anti-Human IFNAR1
Briakinumab
Anti-Human IL 12/23
Atezolizumab
Anti-Human PD-L1
Camidanlumab
Anti-Human CD25
Avelumab
Anti-Human PD-L1
Camrelizumab
Anti-Human PD-1
Basiliximab
Anti-Human IL-2R
Cemiplimab
Anti-Human PD-1
Cetuximab
Anti-Human EGFR
Nivolumab
Anti-Human PD-1
Daclizumab
Anti-Human CD25 (IL-2R)
Obinutuzumab
Anti-Human CD20
Daratumumab
Anti-Human CD38
Olaratumab
Anti-Human PDGFR
Denosumab
Anti-Human RANKL
Oxelumab
Anti-Human OX40L
Dinutuximab
Anti-Human GD2
Palivizumab
Anti-RSV F Protein
Dostarlimab
Anti-Human PD-1
Panitumumab
Anti-Human EGFR
Durvalumab
Anti-Human PD-L1 (CD274)
Pembrolizumab
Anti-Human PD-1
Elotuzumab
Anti-Human CD319 (SLAMF7)
Pertuzumab
Anti-Human HER2
Emapalumab
Anti-Human IFNy
Polatuzumab
Anti-Human CD79b
Enfortumab
Anti-Human Nectin 4
Ramucirumab
Anti-Human VEGFR2
Gemtuzumab
Anti-Human CD33
Relatimab
Anti-Human LAG-3
Genolimzumab
Anti-Human PD-1
Rituximab
Anti-Human CD20
Glotamab
Anti-Human CD3xCD20
Sarilumab
Anti-Human IL-6
Ibalizumab
Anti-Human CD4
Secukinumab
Anti-Human IL-17A
Inotuzumab
Anti-Human CD22
Sintilimab
Anti-Human PD-1
Ipilimumab
Anti-Human CTLA-4
Spartalizumab
Anti-Human PD-1
Ixekizumab
Anti-Human IL-17A
Tabalumab
Anti-Human CD257
Margetuximab
Anti-erB-2
Tafasitamab
Anti-Human CD19
Margrolimab
Anti-Human CD47
Teclistamab
Anti-Human CD3xBCMA
Mirzotamab
Anti-Human CD276
Teplizumab
Anti-Human CD3
Mogamulizumab
Anti-Human CD194
Tiragolumab
Anti-Human TIGIT
Mosunetuzumab
Anti-Human CD3xCD20
Tislelizumab
Anti-Human PD-1
Natalizumab
Anti-Human CD49D
Tocilizumab
Anti-Human IL-6R
Naxitamab
Anti-Human GD2
Trastuzumab
Anti-Human HER-2
Necitumumab
Anti-Human EGFR
Tremelimumab
Anti-Human CTLA-4
Nirsevimab
Anti-RSV F Protein
還能提供包括帶有標記的生物素和 HRP 以及螢光標記的 APC、PE 以及 Dylight®，滿足多種實驗需求。
Page updated
Report abuse